Kaye, Donald
May 2004
Clinical Infectious Diseases;5/15/2004, Vol. 38 Issue 10, piii
Academic Journal
The article reports that the health experts, in the United States, called for the creation of an international stockpile of life-saving antiviral drugs amid warning signs that a human influenza pandemic may be near. The World Health Organization has said that antiviral drugs and vaccines would be in short supply in the early stages of a long-predicted flu pandemic, and the meeting was called to review global readiness for such a development. There has been an average of 27.5 years between pandemics since 1883. The largest, in 1918-1919, killed 40 to 50 million people, with a mortality rate of 2.2%.


Related Articles

  • Hantaviral Enfeksiyonlar: Türkiye Gündemine Yeni Giren Eski Bir Zoonoz. Karakaş, Ahmet; Babayiğit, Mustafa A. // TAF Preventive Medicine Bulletin;Jan/Feb2011, Vol. 10 Issue 1, p77 

    Hantavirus is rodent-borne, enveloped RNA virus and belonging to Bunyaviridae. It had been isolated from near Hantaan River in South Korea. Hantavirus is a zoonosis that affects thousands of individuals each year throughout the world. It is associated with two main clinical disorders in man:...

  • Virus Resistant to Tamiflu Causing Concern.  // Infectious Disease Alert;Mar2008, Vol. 27 Issue 6, p2 

    The article reports on the resistance of a strain of A/N1H1 influenza virus known as A(H1N1 H274Y) to oseltamivir. It says that 75% of the isolated viruses in Norway are showing resistance while the rate of resistance in the U.S. was 3.8%. According to "New York Times," the officials of the...

  • Very Low Resistance Rates to Tamiflu Reported by Roche.  // Clinical Infectious Diseases;7/1/2007, Vol. 45 Issue 1, piv 

    The article presents a new data, published by the United Nations' World Health Organization (WHO), which shows that patients using antiflu drug Tamiflu by Roche Holding AG rarely developed resistance to it in Japan. Around 0.3 percent of patients indicated resistance to Tamiflu during the...

  • Influenza pandemic intervention planning using InfluSim: pharmaceutical and non- pharmaceutical interventions. Duerr, Hans P.; Brockmann, Stefan O.; Piechotowski, Isolde; Schwehm, Markus; Eichner, Martin // BMC Infectious Diseases;2007, Vol. 7 Issue 1, p1 

    Background: Influenza pandemic preparedness plans are currently developed and refined on national and international levels. Much attention has been given to the administration of antiviral drugs, but contact reduction can also be an effective part of mitigation strategies and has the advantage...

  • ATC/DDD Classification (final).  // WHO Drug Information;2007, Vol. 21 Issue 1, p36 

    A list of anatomical therapeutic chemical (ATC) classifications and defined daily doses (DDD) which was agreed by the World Health Organization (WHO) and will be included in the January 2007 issue of the ATC index is presented. It includes the ocular vascular disorder agents with an ATC code...

  • Antiviral Recommendations for H1N1.  // Travel Medicine Advisor;Sep2009 Supplement, p1 

    The article reports on the antiviral recommendations from the World Health Organization (WHO) regarding the H1N1flu. It recommends the use of neuraminidase inhibitor oseltamivir (Tamiflu®) for patients suffering from severe illness. It notes that WHO advises clinicians on widely infected...

  • Breaking the Waves: Modelling the Potential Impact of Public Health Measures to Defer the Epidemic Peak of Novel Influenza A/H1N1. an der Heiden, Matthias; Buchholz, Udo; Krause, Gérard; Kirchner, Göran; Claus, Hermann; Haas, Walter H. // PLoS ONE;2009, Vol. 4 Issue 12, p1 

    Background: On June 11, 2009, the World Health Organization declared phase 6 of the novel influenza A/H1N1 pandemic. Although by the end of September 2009, the novel virus had been reported from all continents, the impact in most countries of the northern hemisphere has been limited. The return...

  • Call for comments on draft WHO guidelines on the use of vaccines and antivirals during influenza pandemics.  // Weekly Epidemiological Record;11/1/2002, Vol. 77 Issue 44, p371 

    Calls for comments on draft World Health Organization guidelines on the use of vaccines and antivirals during influenza pandemics. Scope of the document; Deadline for the submission of comments.

  • Uncertainty still surrounds oseltamivir after 13 year old dies.  // BMJ: British Medical Journal (International Edition);1/7/2006, Vol. 332 Issue 7532, p5 

    The article focuses on resistance to oseltamivir (Tamiflu) in two fatal cases of H5N1 avian flu in Vietnam. Observations suggest that drug resistance contributed to the failure of therapy and death of a 13-year-old girl. The viral load declined during treatment of the second patient, but was...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics